Tech Company Financing Transactions
Helix Therapeutics Funding Round
On 11/23/2010, Helix Therapeutics landed $2.5 million in investment from Canaan Partners and Connecticut Innovations.
Transaction Overview
Company Name
Announced On
11/23/2010
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Canaan Partners (Lead Investor) (Timothy Shannon)
Connecticut Innovations (Russell Tweeddale)
Proceeds Purpose
According to Helix officials, the new funds will be used to move forward its proprietary targeted gene modification (TGM) technology platform.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
150 Munson Street 25 Science Park 2nd Floor
New Haven, CT 06511
USA
New Haven, CT 06511
USA
Phone
Website
Email Address
Overview
The company is developing DNA therapeutics that will cause a paradigm shift in the way that common genetic diseases are treated...by permanently curing them.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Catino
Founder
Ranjit Bindra
Founder
Peter Glazer
Founder
Kevin Rakin
Founder
Gerald Vovis
Browse more venture capital transactions:
Prev: 11/22/2010: Hashable venture capital transaction
Next: 11/23/2010: AisleBuyer venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs